These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

601 related articles for article (PubMed ID: 34736923)

  • 1. Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis.
    Coccia M
    Environ Res; 2022 Mar; 204(Pt C):112314. PubMed ID: 34736923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A machine learning algorithm to analyse the effects of vaccination on COVID-19 mortality.
    Magazzino C; Mele M; Coccia M
    Epidemiol Infect; 2022 Sep; 150():e168. PubMed ID: 36093862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparedness of countries to face COVID-19 pandemic crisis: Strategic positioning and factors supporting effective strategies of prevention of pandemic threats.
    Coccia M
    Environ Res; 2022 Jan; 203():111678. PubMed ID: 34280421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 pandemic over 2020 (withlockdowns) and 2021 (with vaccinations): similar effects for seasonality and environmental factors.
    Coccia M
    Environ Res; 2022 May; 208():112711. PubMed ID: 35033552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations make pandemics worse or better: modeling SARS-CoV-2 variants and imperfect vaccination.
    Bugalia S; Tripathi JP; Wang H
    J Math Biol; 2024 Mar; 88(4):45. PubMed ID: 38507066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into COVID-19 Vaccine Development Based on Immunogenic Structural Proteins of SARS-CoV-2, Host Immune Responses, and Herd Immunity.
    Chaudhary JK; Yadav R; Chaudhary PK; Maurya A; Kant N; Rugaie OA; Haokip HR; Yadav D; Roshan R; Prasad R; Chatrath A; Singh D; Jain N; Dhamija P
    Cells; 2021 Oct; 10(11):. PubMed ID: 34831172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network models to evaluate vaccine strategies towards herd immunity in COVID-19.
    Tetteh JNA; Nguyen VK; Hernandez-Vargas EA
    J Theor Biol; 2021 Dec; 531():110894. PubMed ID: 34508758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine Strategy During the SARS-CoV-2 Pandemic: What School Nurses Need to Know.
    Barnby E; Reynolds M; Gordon J
    NASN Sch Nurse; 2021 Nov; 36(6):316-322. PubMed ID: 34060925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of the COVID-19 pandemic on routine immunization services in Yerevan and vaccinations against COVID-19 in Armenia.
    Melkonyan N; Badalyan A; Hovhannisyan H; Poghosyan K
    J Infect Dev Ctries; 2022 Nov; 16(11):1687-1695. PubMed ID: 36449639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
    Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
    Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of vaccine prioritization strategies on mitigating COVID-19: an agent-based simulation study using an urban region in the United States.
    Tatapudi H; Das R; Das TK
    BMC Med Res Methodol; 2021 Dec; 21(1):272. PubMed ID: 34865617
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Which vaccination strategy against COVID-19?
    De Matteis A; Turkmen Ceylan FB; Urpis E
    Int Health; 2023 Mar; 15(2):150-160. PubMed ID: 35640006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Attack Rate and Population Immunity in Southern New England, March 2020 to May 2021.
    Tran TN; Wikle NB; Yang F; Inam H; Leighow S; Gentilesco B; Chan P; Albert E; Strong ER; Pritchard JR; Hanage WP; Hanks EM; Crawford FW; Boni MF
    JAMA Netw Open; 2022 May; 5(5):e2214171. PubMed ID: 35616938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracking Public Attitudes Toward COVID-19 Vaccination on Tweets in Canada: Using Aspect-Based Sentiment Analysis.
    Jang H; Rempel E; Roe I; Adu P; Carenini G; Janjua NZ
    J Med Internet Res; 2022 Mar; 24(3):e35016. PubMed ID: 35275835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Third Wave of the COVID-19 Pandemic: Prominence of Initial Public Health Interference.
    Mukherjee S; Ray SK
    Infect Disord Drug Targets; 2022; 22(4):e080222200919. PubMed ID: 35135456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study.
    Chen Z; Zheng W; Wu Q; Chen X; Peng C; Tian Y; Sun R; Dong J; Wang M; Zhou X; Zhao Z; Zhong G; Yan X; Liu N; Hao F; Zhao S; Zhuang T; Yang J; Azman AS; Yu H
    BMC Med; 2022 Apr; 20(1):130. PubMed ID: 35369871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Long Road Toward COVID-19 Herd Immunity: Vaccine Platform Technologies and Mass Immunization Strategies.
    Frederiksen LSF; Zhang Y; Foged C; Thakur A
    Front Immunol; 2020; 11():1817. PubMed ID: 32793245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring income-associated inequalities in COVID-19 vaccination on a global scale: a modeling study.
    Amimo F; Magit A
    J Public Health Policy; 2023 Sep; 44(3):449-463. PubMed ID: 37604927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Humoral immunity against SARS-CoV-2 in workers of social health care centers of Castilla y León after vaccination with the BNT162b2 mRNA vaccine from Pfizer/Biontech.].
    Casas Fischer R
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34690347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.